Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 20, 2022, to report its first quarter 2022 financial results. The filing primarily references a press release (Exhibit 99.1) detailing these results. While the specific financial figures are not embedded within the 8-K itself, this report serves as the official notification of the company's performance during the period ended March 31, 2022. Investors should note that this 8-K is a procedural filing to furnish the earnings release. The forward-looking statements section highlights the inherent risks and uncertainties in the company's business, including the impact of public health emergencies like COVID-19, healthcare cost trends, regulatory changes (including the Affordable Care Act), economic conditions, and competitive pressures. The company also flags risks related to its PBM business, cybersecurity, government program compliance (Medicare/Medicaid), and potential M&A activities.
Key Highlights
- 1Filing of an 8-K on April 20, 2022, to report first quarter 2022 financial results.
- 2The primary content of the report is a press release (Exhibit 99.1) detailing financial performance for the quarter ended March 31, 2022.
- 3This filing is a formal notification of the company's results, with detailed figures expected in the accompanying press release.
- 4The report includes a comprehensive 'Forward-Looking Statements' section outlining potential risks and uncertainties.
- 5Key risks mentioned include the impact of pandemics (like COVID-19), healthcare cost inflation, regulatory environments (ACA, Medicare/Medicaid), and PBM business operations.
- 6Cybersecurity threats and potential M&A activities are also identified as areas of risk.
- 7The company cautions investors against undue reliance on forward-looking statements due to the inherent unpredictability of future events.